{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:08:59Z","timestamp":1789520939831,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008868","name":"Jiangsu Science and Technology Department","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008868","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002338","name":"Ministry of Education of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013058","name":"Jiangsu Provincial Key Research and Development Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013280","name":"Major Basic Research Project of the Natural Science Foundation of the Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013280","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012462","name":"Collaborative Innovation Center of Suzhou Nano Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012462","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.biomaterials.2020.120190","type":"journal-article","created":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T02:32:58Z","timestamp":1591929178000},"page":"120190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":112,"special_numbering":"C","title":["Oxaliplatin-\/NLG919 prodrugs-constructed liposomes for effective chemo-immunotherapy of colorectal cancer"],"prefix":"10.1016","volume":"255","author":[{"given":"Fengyun","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangzhu","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danlei","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2020.120190_bib1","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJMra040958","article-title":"Drug therapy - systemic therapy for colorectal cancer","volume":"352","author":"Meyerhardt","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biomaterials.2020.120190_bib2","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/gast.2003.50044","article-title":"Colorectal cancer screening and surveillance: clinical guidelines and rationale - update based on new evidence","volume":"124","author":"Winawer","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biomaterials.2020.120190_bib3","doi-asserted-by":"crossref","first-page":"627","DOI":"10.7326\/0003-4819-149-9-200811040-00243","article-title":"Screening for colorectal cancer: US preventive services task force recommendation statement","volume":"149","author":"Calonge","year":"2008","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.biomaterials.2020.120190_bib4","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cell.2018.09.035","article-title":"A paradigm shift in cancer immunotherapy: from enhancement to normalization","volume":"175","author":"Sanmamed","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.biomaterials.2020.120190_bib5","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1126\/science.342.6165.1432","article-title":"Cancer immunotherapy","volume":"342","author":"Couzin-Frankel","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.biomaterials.2020.120190_bib6","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1172\/JCI80011","article-title":"Anti-PD-1\/PD-L1 therapy of human cancer: past, present, and future","volume":"125","author":"Chen","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biomaterials.2020.120190_bib7","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1158\/1078-0432.CCR-13-3271","article-title":"Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy","volume":"20","author":"Taube","year":"2014","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.biomaterials.2020.120190_bib8","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1021\/acs.nanolett.8b04296","article-title":"Nanoenabled modulation of acidic tumor microenvironment reverses anergy of infiltrating T cells and potentiates anti-PD-1 therapy","volume":"19","author":"Zhang","year":"2019","journal-title":"Nano Lett."},{"key":"10.1016\/j.biomaterials.2020.120190_bib9","doi-asserted-by":"crossref","first-page":"1805888","DOI":"10.1002\/adma.201805888","article-title":"Tumor microenvironment-activatable prodrug vesicles for nanoenabled cancer chemoimmunotherapy combining immunogenic cell death induction and CD47 blockade","volume":"31","author":"Zhou","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2020.120190_bib10","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/nri2233","article-title":"Creating immune privilege: active local suppression that benefits friends, but protects foes","volume":"8","author":"Mellor","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biomaterials.2020.120190_bib11","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nri3902","article-title":"Immunological hallmarks of stromal cells in the tumour microenvironment","volume":"15","author":"Turley","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biomaterials.2020.120190_bib12","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.3389\/fimmu.2017.01360","article-title":"Indoleamine 2,3-dioxygenase and tolerance: where are we now?","volume":"8","author":"Mellor","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biomaterials.2020.120190_bib13","doi-asserted-by":"crossref","first-page":"1902960","DOI":"10.1002\/adma.201902960","article-title":"Self-amplified drug delivery with light-inducible nanocargoes to enhance cancer immunotherapy","volume":"31","author":"Feng","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2020.120190_bib14","doi-asserted-by":"crossref","first-page":"11041","DOI":"10.1021\/acsnano.8b05189","article-title":"Breast cancer chemo-immunotherapy through liposomal delivery of an immunogenic cell death stimulus plus interference in the Ido-1 pathway","volume":"12","author":"Lu","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2020.120190_bib15","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nrd4596","article-title":"Big opportunities for small molecules in immuno-oncology","volume":"14","author":"Adams","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biomaterials.2020.120190_bib16","doi-asserted-by":"crossref","first-page":"14854","DOI":"10.1021\/jacs.5b10182","article-title":"A Pt(IV) pro-drug preferentially targets indoleamine-2,3-dioxygenase, providing enhanced ovarian cancer immuno-chemotherapy","volume":"137","author":"Awuah","year":"2015","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biomaterials.2020.120190_bib17","doi-asserted-by":"crossref","first-page":"12680","DOI":"10.1002\/anie.201906288","article-title":"Organic semiconducting pro-nanostimulants for near-infrared photoactivatable cancer immunotherapy","volume":"58","author":"Li","year":"2019","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.biomaterials.2020.120190_bib18","doi-asserted-by":"crossref","first-page":"11748","DOI":"10.1021\/ja505212y","article-title":"Combination of small molecule prodrug and nanodrug delivery: amphiphilic drug-drug conjugate for cancer therapy","volume":"136","author":"Huang","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biomaterials.2020.120190_bib19","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1021\/ar200017e","article-title":"Lipoprotein-inspired nanoparticles for cancer theranostics","volume":"44","author":"Ng","year":"2011","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.biomaterials.2020.120190_bib20","first-page":"1489","article-title":"Liposomal oxaliplatin in the treatment of advanced cancer: A phase I study","volume":"26","author":"Stathopoulos","year":"2006","journal-title":"Anticancer Res."},{"key":"10.1016\/j.biomaterials.2020.120190_bib21","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jconrel.2009.02.023","article-title":"Oxaliplatin encapsulated in PEG-coated cationic liposomes induces significant tumor growth suppression via a dual-targeting approach in a murine solid tumor model","volume":"137","author":"Abu Lila","year":"2009","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2020.120190_bib22","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1002\/chem.201203159","article-title":"Facile preparation of mono-, di- and mixed-carboxylato platinum(IV) complexes for versatile anticancer prodrug design","volume":"19","author":"Zhang","year":"2013","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.biomaterials.2020.120190_bib23","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.1021\/ja909475m","article-title":"Prodrugs forming high drug loading multifunctional nanocapsules for intracellular cancer drug delivery","volume":"132","author":"Shen","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biomaterials.2020.120190_bib24","doi-asserted-by":"crossref","first-page":"8890","DOI":"10.1021\/acsnano.9b02466","article-title":"Nanoclustered cascaded enzymes for targeted tumor starvation and deoxygenation-activated chemotherapy without systemic toxicity","volume":"13","author":"Ma","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2020.120190_bib25","doi-asserted-by":"crossref","first-page":"4182","DOI":"10.1038\/ncomms5182","article-title":"Self-assembled nanoscale coordination polymers with trigger release properties for effective anticancer therapy","volume":"5","author":"Liu","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2020.120190_bib26","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jconrel.2012.06.004","article-title":"Co-delivery of daunomycin and oxaliplatin by biodegradable polymers for safer and more efficacious combination therapy","volume":"163","author":"Xiao","year":"2012","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2020.120190_bib27","first-page":"256","article-title":"Review of Cisplatin and oxaliplatin in current immunogenic and monoclonal antibody treatments","volume":"8","author":"Mehmood","year":"2014","journal-title":"Oncol. Rev."},{"key":"10.1016\/j.biomaterials.2020.120190_bib28","doi-asserted-by":"crossref","first-page":"1803001","DOI":"10.1002\/adma.201803001","article-title":"Binary cooperative prodrug nanoparticles improve immunotherapy by synergistically modulating immune tumor microenvironment","volume":"30","author":"Feng","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2020.120190_bib29","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1038\/s41467-017-01651-9","article-title":"Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression","volume":"8","author":"Lu","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2020.120190_bib30","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","article-title":"Liposomal drug delivery systems: from concept to clinical applications","volume":"65","author":"Allen","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2020.120190_bib31","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1182\/blood-2009-09-246124","article-title":"Selective inhibition of Ido1 effectively regulates mediators of antitumor immunity","volume":"115","author":"Liu","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.biomaterials.2020.120190_bib32","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1002\/adfm.201504899","article-title":"Cisplatin-prodrug-constructed liposomes as a versatile theranostic nanoplatform for bimodal imaging guided combination cancer therapy","volume":"26","author":"Feng","year":"2016","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.biomaterials.2020.120190_bib33","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/adma.201303360","article-title":"Rational design of polyion complex nanoparticles to overcome cisplatin resistance in cancer therapy","volume":"26","author":"Yang","year":"2014","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2020.120190_bib34","doi-asserted-by":"crossref","first-page":"14652","DOI":"10.1021\/ja9071282","article-title":"Polyvalent oligonucleotide gold nanoparticle conjugates as delivery vehicles for platinum(IV) warheads","volume":"131","author":"Dhar","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biomaterials.2020.120190_bib35","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1021\/acsnano.7b00715","article-title":"Near-infrared-triggered photodynamic therapy with multitasking upconversion nanoparticles in combination with checkpoint blockade for immunotherapy of colorectal cancer","volume":"11","author":"Xu","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2020.120190_bib36","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v26.i6.10","article-title":"Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic","volume":"26","author":"Puri","year":"2009","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.biomaterials.2020.120190_bib37","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/onc.2009.356","article-title":"Immunogenic death of colon cancer cells treated with oxaliplatin","volume":"29","author":"Tesniere","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.biomaterials.2020.120190_bib38","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/intimm\/dxv041","article-title":"Oxaliplatin regulates expression of stress ligands in ovarian cancer cells and modulates their susceptibility to natural killer cell-mediated cytotoxicity","volume":"27","author":"Siew","year":"2015","journal-title":"Int. Immunol."},{"key":"10.1016\/j.biomaterials.2020.120190_bib39","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1158\/2326-6066.CIR-15-0064","article-title":"The interplay of immunotherapy and chemotherapy: harnessing potential synergies","volume":"3","author":"Emens","year":"2015","journal-title":"Cancer Immunology Research"},{"key":"10.1016\/j.biomaterials.2020.120190_bib40","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1126\/science.1208347","article-title":"Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice","volume":"334","author":"Michaud","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.biomaterials.2020.120190_bib41","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/978-1-60761-869-0_19","article-title":"Indoleamine 2,3-dioxygenase and regulatory function: tryptophan starvation and beyond","volume":"677","author":"Orabona","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.biomaterials.2020.120190_bib42","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1007\/s11095-016-1961-x","article-title":"The mystery of antibodies against polyethylene glycol (PEG) - what do we know?","volume":"33","author":"Lubich","year":"2016","journal-title":"Pharmaceut. Res."},{"key":"10.1016\/j.biomaterials.2020.120190_bib43","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.celrep.2015.08.077","article-title":"Tumor-expressed Ido recruits and activates MDSCs in a treg-dependent manner","volume":"13","author":"Holmgaard","year":"2015","journal-title":"Cell Rep."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961220304361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961220304361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T16:55:19Z","timestamp":1758905719000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961220304361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":43,"alternative-id":["S0142961220304361"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2020.120190","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oxaliplatin-\/NLG919 prodrugs-constructed liposomes for effective chemo-immunotherapy of colorectal cancer","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2020.120190","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120190"}}